You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 5, May 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human Immunodeficiency Virus-Specific IgA in Infants Born to Human Immunodeficiency Virus-Seropositive Women

Robert A. Livingston, MD, MPH; Nancy Hutton, MD; Neal A. Halsey, MD; Richard L. Kline, MS; Mary Joyner, RN, CPNP; Thomas C. Quinn, MD, MSc

Arch Pediatr Adolesc Med. 1995;149(5):503-507.


Abstract

Objective
To determine the sensitivity and specificity of human immunodeficiency virus (HIV)–specific IgA for vertically transmitted HIV infection, particularly during the first month of life.

Design/Setting/Patients
Prospective cohort study of 140 infants born to HIV-seropositive women in a large urban teaching hospital and of 248 older infants and children referred for diagnosis and treatment of HIV infection.

Main Outcome Measures
The HIV-specific IgA immunoblot results were compared with the infection status of patients as determined by Centers for Disease Control and Prevention (Atlanta, Ga) criteria or by sequential early diagnostic assays for HIV. Sensitivity, specificity, and predictive values were calculated for each age range.

Results
Among infants studied from birth, the rate of vertical transmission of HIV was 21.6% (25/116). The sensitivity of HIV-specific IgA for the first month of life was 8.0% (2/25), and the specificity was 90.1% (82/91). Sensitivity increased progressively during the first year of life, and the negative predictive value was 94.6% by 6 to 8 months of age. The positive predictive value of this assay was 18.2% for neonates but was 96% to 100% after the first month of life.

Conclusions
False-positive test results for HIV-specific IgA occurred with diminishing frequency during the first 4 weeks of life, and the frequency of detectable HIV-specific IgA was similar among the HIV-infected and uninfected groups at this age. Beyond I month of age, detection of HIV-specific IgA is highly specific and is a useful serum-based assay for early diagnosis of HIV infection. These results suggest that maternalfetal transfusion is common and support the hypothesis that the majority of maternal-fetal transmission of HIV occurs around the time of parturition.

(Arch Pediatr Adolesc Med. 1995;149:503-507)



Author Affiliations

From the Departments of Pediatrics (Drs Livingston, Hutton, and Halsey and Ms Joyner) and Medicine (Dr Quinn), The Johns Hopkins University School of Medicine, and the Department of International Health (Dr Halsey), The Johns Hopkins University School of Hygiene and Public Health, Baltimore, Md; and the Laboratory of Immunoregulation, the National Institute ofAllergy and Infectious Diseases, the National Institutes of Health, Bethesda, Md (Mr Kline and Dr Quinn).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis of Human Immunodeficiency Virus Infection Using an Immunoglobulin E-Based Assay
Fletcher et al.
CVI 2000;7:55-57.
ABSTRACT | FULL TEXT  

The Utility of IgA Antibody to Human Immunodeficiency Virus Type 1 in Early Diagnosis of Vertically Transmitted Infection
McIntosh et al.
Arch Pediatr Adolesc Med 1996;150:598-602.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.